Enhanced formulations of lamotrigine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/53 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 9/50 (2006.01) A61K 47/12 (2006.01) A61K 47/32 (2006.01) A61K 47/34 (2006.01) A61K 47/38 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2598948

A once-a-day, extended-release formulation of lamotrigine, exhibiting a significantly similar release rate throughout the GI tract irrespective of the pH of the environment, is provided. The formulation comprises lamotrigine, an organic acid, a release enhancing polymer and a release controlling polymer. The use of the formulation for the treatment of the neurological disorders is also disclosed.

L'invention porte sur une formulation de lamotrigine à libération prolongée, à administrer une fois par jour, présentant une vitesse de libération significativement analogue dans tout le tractus gastro-intestinal indépendamment du pH de l'environnement. La formulation comprend de la lamotrigine, un acide organique, un polymère améliorant la libération et un polymère contrôlant la libération. L'invention porte également sur l'utilisation de la formulation pour le traitement des troubles neurologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enhanced formulations of lamotrigine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhanced formulations of lamotrigine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced formulations of lamotrigine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1425474

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.